The role of innate immunity in atherogenesis11 Guest editor for this article was Linda Curtiss, the Scripps Research Institute. Published, JLR Papers in Press, December 22, 2008.
暂无分享,去创建一个
[1] D. Webb,et al. Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4 , 2008, Journal of Biological Chemistry.
[2] V. Fuster,et al. Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes , 2008, Circulation.
[3] S. Hazen. Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity* , 2008, Journal of Biological Chemistry.
[4] J. Witztum,et al. Oxidation‐specific epitopes are important targets of innate immunity , 2008, Journal of internal medicine.
[5] Arthur S Slutsky,et al. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury , 2008, Cell.
[6] J. Witztum,et al. Natural antibodies in murine atherosclerosis. , 2008, Current drug targets.
[7] S. Gordon,et al. Macrophage scavenger receptors and host-derived ligands. , 2007, Methods.
[8] S. Kaveri,et al. Phosphorylcholine-targeting immunization reduces atherosclerosis. , 2007, Journal of the American College of Cardiology.
[9] J. Witztum,et al. Promise of immune modulation to inhibit atherogenesis. , 2007, Journal of the American College of Cardiology.
[10] L. Herzenberg,et al. Division and differentiation of natural antibody-producing cells in mouse spleen , 2007, Proceedings of the National Academy of Sciences.
[11] E. Brilakis,et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events Published, JLR Papers in Press, November 8, 2006. , 2007, Journal of Lipid Research.
[12] Stanley L. Hazen,et al. Oxidized phosphatidylserine–CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells , 2006, The Journal of experimental medicine.
[13] P. Shah,et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. , 2006, Atherosclerosis.
[14] S. Gordon,et al. The interaction of macrophage receptors with bacterial ligands , 2006, Expert Reviews in Molecular Medicine.
[15] A. Brewer,et al. GATA factors in vertebrate heart development and disease , 2006, Expert Reviews in Molecular Medicine.
[16] J. Witztum,et al. A Natural Antibody to Oxidized Cardiolipin Binds to Oxidized Low-Density Lipoprotein, Apoptotic Cells, and Atherosclerotic Lesions , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[17] Peter Libby,et al. The immune response in atherosclerosis: a double-edged sword , 2006, Nature Reviews Immunology.
[18] J. Witztum,et al. Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.
[19] D. S. Worrall,et al. Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[20] G. Getz. Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400013-JLR200 , 2005, Journal of Lipid Research.
[21] K. Elkon,et al. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo , 2005, Autoimmunity.
[22] P. Shah,et al. Immunomodulation of atherosclerosis: implications for vaccine development. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[23] J. Witztum,et al. The role of natural antibodies in atherogenesis. , 2005, Journal of lipid research.
[24] L. Herzenberg,et al. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.
[25] Jianfei Jiang,et al. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine. , 2004, Free radical biology & medicine.
[26] J. Witztum,et al. Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory , 2004, The Journal of experimental medicine.
[27] B. Strauss,et al. Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.
[28] R. Hardy,et al. Selection during development of VH11+ B cells: a model for natural autoantibody‐producing CD5+ B cells , 2004, Immunological reviews.
[29] J. Berliner,et al. Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8 , 2003, Journal of Biological Chemistry.
[30] J. Witztum,et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.
[31] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[32] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[33] J. Witztum,et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Sobue,et al. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease , 2002, Acta Neuropathologica.
[35] E. Dennis,et al. Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids , 2002, The Journal of Biological Chemistry.
[36] B. Binder,et al. Oxidized Membrane Vesicles and Blebs From Apoptotic Cells Contain Biologically Active Oxidized Phospholipids That Induce Monocyte‐Endothelial Interactions , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[37] D. Steinberg,et al. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. , 2001, Journal of lipid research.
[38] G. Silverman,et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.
[39] A. Lustig,et al. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] Y. Chao,et al. Infectious Agents Are Not Necessary for Murine Atherogenesis , 2000, The Journal of experimental medicine.
[41] E. Dennis,et al. The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.
[42] M. Pepys,et al. C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction , 1999, The Journal of experimental medicine.
[43] E. Dennis,et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Dennis,et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.
[45] V. Monnier,et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. , 1997, The Journal of clinical investigation.
[46] J. Witztum,et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.
[47] J. Witztum,et al. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. , 1994, The Journal of clinical investigation.
[48] M. Krieger. Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. , 1992, Trends in biochemical sciences.
[49] M. Freeman,et al. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Ylä-Herttuala,et al. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. , 1990, Arteriosclerosis.
[51] J L Witztum,et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.
[52] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.